Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

GPR39 agonist reduces alcohol intake in mouse model of alcohol use disorder

Feb. 19, 2019

Addex and Indivior intend to accelerate additional GABA-B PAM compounds for addiction

Feb. 14, 2019

Antidote Therapeutics to collaborate with NCI on development of ATI-1013

Feb. 8, 2019

Phase Ib data support expansion of indication for BioXcel's BXCL-501

Feb. 5, 2019

Phase II data for PF-04457845 as potential treatment of cannabis withdrawal and dependence

Jan. 15, 2019

Nanoscavenger versus neurotoxins

Jan. 7, 2019

ITI-333 shows promise for the treatment of pain and substance abuse-derived disorders

Dec. 24, 2018

Adial engages CRO to oversee phase III trial of AD-04 for alcohol use disorder

Nov. 23, 2018

Weekly and monthly Buvidal approved in Europe for opioid dependence

Nov. 23, 2018

Blocking BigLEN-GRP171 signaling reduces opioid addiction and withdrawal in mice

Nov. 15, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...